NDC properties for NDC 9 0078-0630
NDC item 00078063019
| NDC 9 | 0078-0630 |
|---|---|
| NDC 10 | 0078-0630-19 |
| NDC Item | 00078063019 |
| packaging | 8 in 1 BOX, UNIT-DOSE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 500733 |
| Imprint code | NVR;AVCI |
| Labeler | Novartis Pharmaceuticals Corporation |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2013-03-22 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 49502034608
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-08 |
| NDC Item | 49502034608 |
| packaging | 8 in 1 BOX, UNIT-DOSE |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 519453 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 49502034611
| NDC 9 | 49502-346 |
|---|---|
| NDC 10 | 49502-346-11 |
| NDC Item | 49502034611 |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 519453 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time low | 2020-09-24 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 49502040108
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-08 |
| NDC Item | 49502040108 |
| packaging | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-08) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |
NDC item 49502040109
| NDC 9 | 49502-401 |
|---|---|
| NDC 10 | 49502-401-09 |
| NDC Item | 49502040109 |
| packaging | 8 CAPSULE in 1 BOX, UNIT-DOSE (49502-401-09) |
| COLORTEXT | WHITE(clear, colorless) |
| Color | C48325 __ |
| FDA SPL set id | 859659 |
| Imprint code | MYL;TPH |
| Labeler | Viatris Specialty LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Marketing effective time high | 2026-12-31 |
| Marketing effective time low | 2021-09-01 |
| Marketing status | COMPLETED |
| NDA | NDA201688 |
| Score | 1 |
| Shape | C48336 |
| Size | 18 mm |